When Pradeep Singh was first diagnosed with acute lymphoblastic leukaemia in 2021, competitive cycling was the last thing on his mind. Now 27, the national-level cyclist recalls the months of chemotherapy and maintenance treatment that followed his diagnosis. For a time, the disease appeared under control. But in 2023, two years into remission, it returned. …
ABB India reports record order growth in Q4 despite margin pressures
NEW DELHI, FEBRUARY 20, 2026 – ABB India announced its highest fourth-quarter order intake in the last five years, with a remarkable 52% surge in orders for the fourth quarter (October-December), which reached INR 4,096 crore. This strong quarterly performance contributed to a record-high order intake of INR 14,115 crore for the full year 2025, an …
iDefender Expands Enterprise Execution Intelligence with Vivechana, Niyantā, Niyantā AI and Bazar Bandhu
New Delhi, India | iDefender IT Services Pvt. Ltd., an enterprise IT and cybersecurity solutions provider founded in 2012, today announced the continued evolution of its integrated solution ecosystem—Vivechana, Niyantā, Niyantā AI, and Bazar Bandhu—designed to bring intelligence, governance, automation, and operational control to enterprise and infrastructure environments. With over 500+ enterprise deployments, 99.9% platform …
Indigenous CAR-T Therapy Signals New Phase for India’s Cancer Care and Biotech Manufacturing
When Ms. Arora’s cancer returned, the emotional weight of relapse was immediate. Having already undergone standard lines of treatment for non-Hodgkin’s lymphoma (NHL) after her diagnosis in 2022, she now faced a narrower set of options—each complex, each uncertain. “I remember feeling that the ground had shifted again,” she says. “But my medical team walked …




